MapLight Therapeutics, Inc. (MPLT)

MapLight Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	33.47	38.25	79.77	27.67
Short-Term Investments	27.01	70.54	-	-
Cash & Short-Term Investments	60.47	108.8	79.77	27.67
Cash Growth	-24.19%	36.39%	188.34%	-
Prepaid Expenses	12.73	5.81	3.84	4.37
Total Current Assets	73.2	114.6	83.6	32.03
Property, Plant & Equipment	6.9	7.56	6.59	7.12
Long-Term Investments	-	11.38	0.99	-
Other Long-Term Assets	4.02	3.37	0.23	0.23
Total Assets	84.12	136.92	91.41	39.39
Accounts Payable	2.1	1.91	3.25	3.6
Accrued Expenses	9.12	9.99	6.76	2.79
Current Portion of Leases	0.83	0.78	0.5	0.35
Current Unearned Revenue	2.41	3.24	4.2	5.86
Total Current Liabilities	14.98	15.92	14.7	12.6
Long-Term Leases	5.37	5.8	5.43	5.92
Total Liabilities	20.36	21.72	20.13	18.52
Additional Paid-In Capital	6.44	5.58	4.2	3.12
Retained Earnings	-251.55	-199.37	-121.79	-66.08
Comprehensive Income & Other	0.05	0.16	-	-
Total Common Equity	-245.06	-193.63	-117.59	-62.96
Shareholders' Equity	63.76	115.2	71.28	20.87
Total Liabilities & Equity	84.12	136.92	91.41	39.39
Total Debt	6.21	6.58	5.92	6.27
Net Cash (Debt)	54.27	102.22	73.85	21.39
Net Cash Growth	-26.51%	38.42%	245.17%	-
Net Cash Per Share	71.33	138.84	111.94	38.41
Filing Date Shares Outstanding	0.79	0.76	0.67	0.56
Total Common Shares Outstanding	0.79	0.76	0.67	0.56
Working Capital	58.22	98.68	68.91	19.44
Book Value Per Share	-310.46	-254.32	-176.19	-113.03
Tangible Book Value	-245.06	-193.63	-117.59	-62.96
Tangible Book Value Per Share	-310.46	-254.32	-176.19	-113.03
Machinery	3.33	3.28	2.77	2.22
Leasehold Improvements	0.01	0.01	0.01	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q